Leronlimab treats the immune dysregulation, regardless of the strain of Covid, or presumably other pathogens.
Leronlimab will be the go-to therapeutic when pandemic influenza emerges in the near or distant future.
(6)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-